Adding Fludarabine to Cyclophophamide-dexamethason induction therapy impair stem cell harvest in MM: Report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial

Hans Erik Johnsen, Lene Meldgaard Knudsen, Anne Kærsgaard Mylin, Peter Gimsing, Henrik Gregersen, Niels Abildgaard, Niels Frost Andersen, Torben Plesner, Annette Juul Vangsted, Torben Mourits-Andersen, on behalf of the Nordic Myeloma Study Group

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Fingeraftryk

Dyk ned i forskningsemnerne om 'Adding Fludarabine to Cyclophophamide-dexamethason induction therapy impair stem cell harvest in MM: Report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial'. Sammen danner de et unikt fingeraftryk.

Pharmacology, Toxicology and Pharmaceutical Science